Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis Renshall

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|December 24, 2025
Transfer of interferon beta in term placentaeEleanor Doman, Angelos Evangelinos, Lewis Renshall, et al.
Molecules (Basel, Switzerland)|December 5, 2019
Tetramethoxystilbene-Loaded Liposomes Restore Reactive-Oxygen-Species-Mediated Attenuation of Dilator Responses in Rat Aortic Vessels Ex vivoAzziza Zaabalawi, Cai Astley, Lewis Renshall, et al.
Molecular Pharmaceutics|November 29, 2021
Conjugation to PEG as a Strategy to Limit the Uptake of Drugs by the Placenta: Potential Applications for Drug Administration in PregnancyAbbie Dodd, Az Alddien Natfji, Angelos Evangelinos, et al.
Pharmaceutics|October 27, 2022
Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3',4,5'-TetramethoxystilbeneAzziza Zaabalawi, Lewis Renshall, Frances Beards, et al.
American Journal of Physiology. Cell Physiology|July 16, 2024
Glucose influences endometrial receptivity to embryo implantation through O-GlcNAcylation-mediated regulation of the cytoskeletonPeter T Ruane, Isabel Paterson, Beth Reeves, et al.
Pulmonary Circulation|December 21, 2017
Selective improvement of pulmonary arterial hypertension with a dual ET<sub>A</sub>/ET<sub>B</sub> receptors antagonist in the apolipoprotein E<sup>-/-</sup> model of PAH and atherosclerosisLewis Renshall, Nadine Arnold, Laura West, et al.
Theranostics|December 22, 2025
Targeted nanoparticles for placenta-specific drug delivery in pregnant rhesus macaquesJenna K Schmidt, Ann M Mitzey, Logan T Keding, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|December 24, 2025
Transfer of interferon beta in term placentaeEleanor Doman, Angelos Evangelinos, Lewis Renshall, et al.
Molecules (Basel, Switzerland)|December 5, 2019
Tetramethoxystilbene-Loaded Liposomes Restore Reactive-Oxygen-Species-Mediated Attenuation of Dilator Responses in Rat Aortic Vessels Ex vivoAzziza Zaabalawi, Cai Astley, Lewis Renshall, et al.
Molecular Pharmaceutics|November 29, 2021
Conjugation to PEG as a Strategy to Limit the Uptake of Drugs by the Placenta: Potential Applications for Drug Administration in PregnancyAbbie Dodd, Az Alddien Natfji, Angelos Evangelinos, et al.
Pharmaceutics|October 27, 2022
Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3',4,5'-TetramethoxystilbeneAzziza Zaabalawi, Lewis Renshall, Frances Beards, et al.
American Journal of Physiology. Cell Physiology|July 16, 2024
Glucose influences endometrial receptivity to embryo implantation through O-GlcNAcylation-mediated regulation of the cytoskeletonPeter T Ruane, Isabel Paterson, Beth Reeves, et al.
Pulmonary Circulation|December 21, 2017
Selective improvement of pulmonary arterial hypertension with a dual ET<sub>A</sub>/ET<sub>B</sub> receptors antagonist in the apolipoprotein E<sup>-/-</sup> model of PAH and atherosclerosisLewis Renshall, Nadine Arnold, Laura West, et al.
Theranostics|December 22, 2025
Targeted nanoparticles for placenta-specific drug delivery in pregnant rhesus macaquesJenna K Schmidt, Ann M Mitzey, Logan T Keding, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
Nature Communications|November 16, 2019
A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertensionNadine D Arnold, Josephine A Pickworth, Laura E West, et al.
Pageof 1